Gluconorm P 7.5mg/500mg Tablet
By Gluconorm P
Rx
10 Tablet in a Strip

Composition
Pioglitazone(7.5mg) + Metformin(500mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
October, 2025

liver
When taking Gluconorm P 7.5mg/500mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment while using this medication. It is advisable to consult your doctor before starting Gluconorm P 7.5mg/500mg Tablet. Typically, treatment with this medication begins at a low dose for individuals with mild to moderate liver disease. However, it is not recommended for patients with severe liver disease. If you have any concerns or liver-related symptoms, seek guidance from your healthcare provider.

kidney
Gluconorm P 7.5mg/500mg Tablet should be used carefully if you have kidney disease. Your doctor may need to adjust the dose. Avoid this medicine if you have severe kidney issues. Regularly monitor your kidney function while using Gluconorm P 7.5mg/500mg Tablet.

alcohol
It is unsafe to drink alcohol while taking Gluconorm P 7.5mg/500mg Tablet. Avoid alcohol consumption with this medication.

driving
If you experience symptoms of low or high blood sugar while taking Gluconorm P 7.5mg/500mg Tablet, avoid driving as your ability to drive may be affected.

pregnancy
Gluconorm P 7.5mg/500mg Tablet may not be safe during pregnancy. Animal studies have shown potential harm to the fetus. Your doctor will consider the risks and benefits before prescribing. Please consult your doctor regarding its use in pregnancy.

breastfeeding
Caution is advised while breastfeeding and using Gluconorm P 7.5mg/500mg Tablet. Limited data indicates potential harm to the baby through breastmilk exposure.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
₹54.5
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024